Antonio Vitale

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Combination Therapy

Mesenchymal Stem Cells

Depressive Symptoms

Top Venues

Pharmaceuticals (Basel, Switzerland)

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, Arianna Marinello, Laura Giordano, Emilio Bria, Alessio Stefani, Antonio Vitale, Luca Toschi, Ettore D'Argento, Armando Santoro
Response to first-line pembrolizumab in metastatic KRAS -mutated non-small-cell lung cancer. Future oncology (London, England) (2024)
Emanuele Vita, Federico Monaca, Domenico Milardi, Luca Mastrantoni, Alessio Stefani, Edoardo Vergani, Jacopo Russo, Diletta Barone, Ileana Sparagna, Antonio Vitale, Alessandro Scala, Denis Occhipinti, Mariantonietta Di Salvatore, Alfredo Pontecorvi, Giampaolo Tortora, Emilio Bria
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer. Cancer (2024)
Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, Arianna Marinello, Laura Giordano, Emilio Bria, Alessio Stefani, Antonio Vitale, Luca Toschi, Ettore D'Argento, Armando Santoro
Response to first-line pembrolizumab in metastatic KRAS -mutated non-small-cell lung cancer. Future oncology (London, England) 20 (7) (2024)
Emanuele Vita, Federico Monaca, Domenico Milardi, Luca Mastrantoni, Alessio Stefani, Edoardo Vergani, Jacopo Russo, Diletta Barone, Ileana Sparagna, Antonio Vitale, Alessandro Scala, Denis Occhipinti, Mariantonietta Di Salvatore, Alfredo Pontecorvi, Giampaolo Tortora, Emilio Bria
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancer. Cancer 130 (15) (2024)
Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, Arianna Marinello, Laura Giordano, Emilio Bria, Alessio Stefani, Antonio Vitale, Luca Toschi, Ettore D'Argento, Armando Santoro
Response to first-line pembrolizumab in metastatic KRAS -mutated non-small-cell lung cancer. Future oncology (London, England) 20 (7) (2024)
Merlino Lucia, D'Ovidio Giulia, Viviana Matys, Maria Grazia Piccioni, Porpora Maria Grazia, Roberto Senatori, Maria Federica Viscardi, Antonio Vitale, Carlo Della Rocca, null On Behalf Of Policlinico Umberto I Collaborators
Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Merlino Lucia, D'Ovidio Giulia, Viviana Matys, Maria Grazia Piccioni, Porpora Maria Grazia, Roberto Senatori, Maria Federica Viscardi, Antonio Vitale, Carlo Della Rocca, null On Behalf Of Policlinico Umberto I Collaborators
Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Merlino Lucia, D'Ovidio Giulia, Viviana Matys, Maria Grazia Piccioni, Porpora Maria Grazia, Roberto Senatori, Maria Federica Viscardi, Antonio Vitale, Carlo Della Rocca, null On Behalf Of Policlinico Umberto I Collaborators
Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Merlino Lucia, D'Ovidio Giulia, Viviana Matys, Maria Grazia Piccioni, Porpora Maria Grazia, Roberto Senatori, Maria Federica Viscardi, Antonio Vitale, Carlo Della Rocca, null On Behalf Of Policlinico Umberto I Collaborators
Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)